Results 1 to 10 of about 274,305 (384)
Some of the next articles are maybe not open access.

TLR4-Based Immunotherapeutics in Cancer: A Review of the Achievements and Shortcomings.

Molecular Pharmaceutics, 2018
Toll-like Receptor 4 (TLR4) agonists have had a long journey in the field of cancer immunotherapy. Nevertheless, despite the remarkable number of the TLR4 ligands that have gone through various preclinical and clinical stages, only two (Bacillus Calmette-
Maryam A. Shetab Boushehri, A. Lamprecht
semanticscholar   +1 more source

Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene.

Science, 1998
A. Poltorak   +13 more
semanticscholar   +1 more source

LPS/TLR4 signal transduction pathway.

Cytokine, 2008
Yong-Chen Lu, W. Yeh, P. Ohashi
semanticscholar   +1 more source

The structural basis of lipopolysaccharide recognition by the TLR4–MD-2 complex

Nature, 2009
B. Park   +5 more
semanticscholar   +1 more source

Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood

Nature Medicine, 2007
Stephen R. Clark   +15 more
semanticscholar   +1 more source

TLR4 mutations are associated with endotoxin hyporesponsiveness in humans

Nature Genetics, 2000
N. Arbour   +8 more
semanticscholar   +1 more source

Noncanonical Inflammasome Activation by Intracellular LPS Independent of TLR4

Science, 2013
N. Kayagaki   +12 more
semanticscholar   +1 more source

Resistin facilitates breast cancer progression via TLR4-mediated induction of mesenchymal phenotypes and stemness properties

Oncogene, 2018
C-H Wang   +15 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy